ERBB2 and breast cancer: When pictilisib is coupled with anastrozole for treating patients with HR+/HER2- early breast cancer, it can significantly inhibit tumour cell proliferation52, but there is no superior benefit when pictilisib is combined with paclitaxel or fulvestrant53,.54